APA (7th ed.) Citation

Sumransub, N., Steinwand, G. K., Cordner, K., Lee, Y., Cao, Q., Allred, J., . . . Sachs, Z. (2024). Patients with TP53 -Mutated Acute Myeloid Leukemia Receiving Intensive Induction Therapy Have Superior Outcomes Due to a Higher Rate of Salvage Therapy: A Single Institution, Retrospective Study. Cancers, 16(16), 2784. https://doi.org/10.3390/cancers16162784

Chicago Style (17th ed.) Citation

Sumransub, Nuttavut, et al. "Patients with TP53 -Mutated Acute Myeloid Leukemia Receiving Intensive Induction Therapy Have Superior Outcomes Due to a Higher Rate of Salvage Therapy: A Single Institution, Retrospective Study." Cancers 16, no. 16 (2024): 2784. https://doi.org/10.3390/cancers16162784.

MLA (9th ed.) Citation

Sumransub, Nuttavut, et al. "Patients with TP53 -Mutated Acute Myeloid Leukemia Receiving Intensive Induction Therapy Have Superior Outcomes Due to a Higher Rate of Salvage Therapy: A Single Institution, Retrospective Study." Cancers, vol. 16, no. 16, 2024, p. 2784, https://doi.org/10.3390/cancers16162784.